Skip to content

Insider · CIK 0001997664

Bill Facteau

director

Files at BCDA (BioCardia, Inc.). First filing Apr 25, 2025, latest Apr 25, 2025.

Bill Facteau files SEC Form 4 as director at BCDA (BioCardia, Inc.). Since Apr 25, 2025, Bill Facteau has reported 1 open-market buy worth $25k and 0 open-market sells worth $0, the latest filed on Apr 25, 2025.

A track record needs three past buys with six months of prices behind them; Bill Facteau has 0, so none is measured yet.

The newest scored trade: bought $25k of BCDA on Apr 23, 2025, filed Apr 25, 2025, scored 56 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$25k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BCDA: BioCardia, Inc.

BCDAOct 9, 2026 · close 1.04

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
56Moderate
BCDAbuy 6
BioCardia, Inc.
$25k
13,123 shares
-+6% from low-40% from high

Transactions

Every row this insider has filed, 5 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jul 6, 2026BCDA
BioCardia, Inc.
AGrant or award
Stock Option (right to buy)derivative
+8,000$0.00$023,729Jul 7, 2026
Dec 8, 2025BCDA
BioCardia, Inc.
AGrant or award
Stock Option (right to buy)derivative
+12,000$0.00$015,729Dec 10, 2025
Apr 23, 2025BCDA
BioCardia, Inc.
POpen-market purchase
Common Stock
+13,123$1.91$25k13,123Apr 25, 2025
Apr 23, 2025BCDA
BioCardia, Inc.
POpen-market purchase
Warrant (right to buy)derivative
+13,123--13,123Apr 25, 2025
Oct 11, 2024BCDA
BioCardia, Inc.
AGrant or award
Stock Option (right to buy)derivative
+829$0.00$03,729Oct 16, 2024

Questions about Bill Facteau

Answered from the filings on this page, as of the latest one.

Is Bill Facteau buying or selling?

Not in the last 12 months. Bill Facteau's latest open-market trade on SEC Form 4 was bought $25k of BCDA on Apr 23, 2025.

How did Bill Facteau's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bill Facteau has 0.

Where does Bill Facteau file Form 4?

Bill Facteau has filed Form 4 at BCDA (BioCardia, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Bill Facteau: insider trades and track record | InsiderTell